← Leaderboards
Benedict Shek Hang Law
Weill Medical Coll Of Cornell Univ
$4,167,074
Attributed
$4,167,074
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $665.9K · FY2017–25$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,167,074 · 3
By mechanism
R01$3,997,574 · 2
R03$169,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Yi Wang$29,689,109
- Rasa Zarnegar$582,671
- Kymora B Scotland$678,785
- Vanessa Bellat$1,505,461
- Ashutosh K Tewari$1,328,463
Others in their field
Other Emerging Leaders on “Treatment Outcome”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$146,927,997
- Beth Baseler · Leidos Biomedical Research, Inc.$73,306,144
- Susan Abushakra · Alzheon, Inc.$47,265,244
Research focus
Treatment OutcomeChemotherapyPropertyTreatment EfficacyTumorX-Ray Computed TomographyDoxorubicinMortalityReticuloendothelial SystemToxic EffectPharmaceutical PreparationsDesignPeptidesUptakeAnimalsBypassFlexibilityBiodistributionMorbidity - Disease RateDrug CarriersDrug KineticsMalignant NeoplasmsImproved OutcomeCombined Modality Therapy
Grant awards (10)
An urinary drug disposing approach for treatment of bladder Cancer$546,617
R01 · FY2025 · CA · contact PI
An urinary drug disposing approach for treatment of bladder Cancer$595,483
R01 · FY2024 · CA · contact PI
An urinary drug disposing approach for treatment of bladder Cancer$665,916
R01 · FY2023 · CA · contact PI
A multiplexed approach to improve tumoral targeting and chemotherapeutic treatment$425,963
R01 · FY2022 · CA · contact PI
A multiplexed approach to improve tumoral targeting and chemotherapeutic treatment$454,761
R01 · FY2021 · CA · contact PI
A multiplexed approach to improve tumoral targeting and chemotherapeutic treatment$467,521
R01 · FY2020 · CA · contact PI
A multiplexed approach to improve tumoral targeting and chemotherapeutic treatment$429,174
R01 · FY2019 · CA · contact PI
A multiplexed approach to improve tumoral targeting and chemotherapeutic treatment$412,139
R01 · FY2018 · CA · contact PI
Investigate peptide-based nanofiber as a multiplexed delivery system to metastatic breast tumors$84,750
R03 · FY2018 · CA · contact PI
Investigate peptide-based nanofiber as a multiplexed delivery system to metastatic breast tumors$84,750
R03 · FY2017 · CA · contact PI